Elizabeth D. Tate

1.6k total citations
44 papers, 1.1k citations indexed

About

Elizabeth D. Tate is a scholar working on Neurology, Rheumatology and Genetics. According to data from OpenAlex, Elizabeth D. Tate has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Neurology, 25 papers in Rheumatology and 15 papers in Genetics. Recurrent topics in Elizabeth D. Tate's work include Autoimmune Neurological Disorders and Treatments (29 papers), Glycogen Storage Diseases and Myoclonus (25 papers) and Genetics and Neurodevelopmental Disorders (15 papers). Elizabeth D. Tate is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (29 papers), Glycogen Storage Diseases and Myoclonus (25 papers) and Genetics and Neurodevelopmental Disorders (15 papers). Elizabeth D. Tate collaborates with scholars based in United States, Canada and United Kingdom. Elizabeth D. Tate's co-authors include Michael R. Pranzatelli, Anna L. Travelstead, Tyler Allison, Nathan R. McGee, Jerry A. Colliver, Steven J. Verhulst, Stephen H. Mott, Joan A. Conry, Steven G. Pavlakis and Darryl C. Longee and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and The Journal of Pediatrics.

In The Last Decade

Elizabeth D. Tate

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth D. Tate United States 22 869 338 262 220 129 44 1.1k
Stacey Clardy United States 18 819 0.9× 125 0.4× 120 0.5× 76 0.3× 195 1.5× 75 1.2k
Saiju Jacob United Kingdom 24 1.9k 2.2× 159 0.5× 83 0.3× 117 0.5× 421 3.3× 95 2.4k
Tena Rosser United States 19 597 0.7× 163 0.5× 185 0.7× 80 0.4× 87 0.7× 43 1.1k
Jean‐Philippe Camdessanché France 25 1.5k 1.7× 133 0.4× 90 0.3× 285 1.3× 249 1.9× 101 2.0k
Núria Solà‐Valls Spain 20 620 0.7× 148 0.4× 67 0.3× 100 0.5× 595 4.6× 42 1.3k
Bianca Teegen Germany 17 627 0.7× 73 0.2× 228 0.9× 48 0.2× 83 0.6× 50 1.0k
Sabrina Matà Italy 16 1.2k 1.4× 118 0.3× 205 0.8× 55 0.3× 215 1.7× 47 1.5k
Rinze F. Neuteboom Netherlands 25 928 1.1× 234 0.7× 203 0.8× 55 0.3× 725 5.6× 71 1.7k
Jean‐Christophe Antoine France 25 1.7k 2.0× 98 0.3× 327 1.2× 120 0.5× 81 0.6× 64 2.1k
Salah Omer United Kingdom 11 769 0.9× 206 0.6× 312 1.2× 31 0.1× 42 0.3× 17 1.2k

Countries citing papers authored by Elizabeth D. Tate

Since Specialization
Citations

This map shows the geographic impact of Elizabeth D. Tate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth D. Tate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth D. Tate more than expected).

Fields of papers citing papers by Elizabeth D. Tate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth D. Tate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth D. Tate. The network helps show where Elizabeth D. Tate may publish in the future.

Co-authorship network of co-authors of Elizabeth D. Tate

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth D. Tate. A scholar is included among the top collaborators of Elizabeth D. Tate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth D. Tate. Elizabeth D. Tate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pranzatelli, Michael R., Elizabeth D. Tate, & Tyler Allison. (2017). Case-control, exploratory study of cerebrospinal fluid chemokines/cytokines and lymphocyte subsets in childhood Tourette syndrome with positive streptococcal markers. Cytokine. 96. 49–53. 14 indexed citations
2.
Pranzatelli, Michael R., Elizabeth D. Tate, & Nathan R. McGee. (2017). Microglial/macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders: A case-control study and reference ranges. Journal of the Neurological Sciences. 381. 285–290. 13 indexed citations
3.
Pranzatelli, Michael R. & Elizabeth D. Tate. (2017). Dexamethasone, Intravenous Immunoglobulin, and Rituximab Combination Immunotherapy for Pediatric Opsoclonus-Myoclonus Syndrome. Pediatric Neurology. 73. 48–56. 23 indexed citations
4.
Tate, Elizabeth D., Nathan R. McGee, & Michael R. Pranzatelli. (2014). Clinical and Demographic Features of 389 Children with OMS: an International Cohort. 4 indexed citations
5.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, & Jerry A. Colliver. (2013). Pediatric Reference Ranges for Proinflammatory and Anti-Inflammatory Cytokines in Cerebrospinal Fluid and Serum by Multiplexed Immunoassay. Journal of Interferon & Cytokine Research. 33(9). 523–528. 24 indexed citations
6.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, et al.. (2013). BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy. Journal of Neuroinflammation. 10(1). 10–10. 37 indexed citations
7.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, & Richard M. Ransohoff. (2013). CCR7 signaling in pediatric opsoclonus–myoclonus: Upregulated serum CCL21 expression is steroid-responsive. Cytokine. 64(1). 331–336. 10 indexed citations
8.
Pranzatelli, Michael R., Elizabeth D. Tate, Nathan R. McGee, et al.. (2012). Key role of CXCL13/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS. Journal of Neuroimmunology. 243(1-2). 81–88. 32 indexed citations
9.
Tate, Elizabeth D., Michael R. Pranzatelli, Steven J. Verhulst, et al.. (2012). Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome. Journal of Child Neurology. 27(7). 875–884. 31 indexed citations
10.
Pranzatelli, Michael R., Elizabeth D. Tate, Anna L. Travelstead, & Steven J. Verhulst. (2011). Chemokine/cytokine profiling after rituximab: Reciprocal expression of BCA-1/CXCL13 and BAFF in childhood OMS. Cytokine. 53(3). 384–389. 20 indexed citations
11.
Pranzatelli, Michael R., Elizabeth D. Tate, Steven J. Verhulst, et al.. (2010). Pediatric Dosing of Rituximab Revisited: Serum Concentrations in Opsoclonus-myoclonus Syndrome. Journal of Pediatric Hematology/Oncology. 32(5). e167–e172. 18 indexed citations
12.
Pranzatelli, Michael R., Elizabeth D. Tate, Anna L. Travelstead, et al.. (2010). B cell depletion therapy for new‐onset opsoclonus‐myoclonus. Movement Disorders. 25(2). 238–242. 40 indexed citations
13.
Pranzatelli, Michael R., et al.. (2009). Insights on Chronic-Relapsing Opsoclonus-Myoclonus From a Pilot Study of Mycophenolate Mofetil. Journal of Child Neurology. 24(3). 316–322. 23 indexed citations
14.
Pranzatelli, Michael R., Elizabeth D. Tate, Anna L. Travelstead, et al.. (2006). Rituximab (anti-CD20) Adjunctive Therapy for Opsoclonus-Myoclonus Syndrome. Journal of Pediatric Hematology/Oncology. 28(9). 585–593. 103 indexed citations
15.
Pranzatelli, Michael R., et al.. (2005). Sleep Disturbance and Rage Attacks in Opsoclonus-Myoclonus Syndrome: Response to Trazodone. The Journal of Pediatrics. 147(3). 372–378. 29 indexed citations
16.
Pranzatelli, Michael R., Kelly Y. Chun, Michael Moxness, Elizabeth D. Tate, & Tyler Allison. (2005). Cerebrospinal Fluid ACTH and Cortisol in Opsoclonus-Myoclonus: Effect of Therapy. Pediatric Neurology. 33(2). 121–126. 13 indexed citations
17.
Pranzatelli, Michael R., Elizabeth D. Tate, Nancy Bass, et al.. (2002). Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia. Pediatric Neurology. 27(5). 384–387. 37 indexed citations
18.
Pranzatelli, Michael R., Israel Hanin, Elizabeth D. Tate, et al.. (1998). Cerebrospinal fluid free choline in movement disorders of paediatric onset. European Journal of Paediatric Neurology. 2(1). 33–39. 2 indexed citations
19.
Pranzatelli, Michael R., Yung‐yu Huang, Elizabeth D. Tate, et al.. (1998). Monoaminergic effects of high‐dose corticotropin in corticotropin‐responsive pediatric opsoclonus‐myoclonus. Movement Disorders. 13(3). 522–528. 18 indexed citations
20.
Pranzatelli, Michael R., et al.. (1995). NEUROBEHAVIORAL AND PSYCHOSOCIAL FUNCTIONING OF CHILDREN WITH OPSOCLONUS‐MYOCLONUS SYNDROME. Developmental Medicine & Child Neurology. 37(10). 915–932. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stacey Clardy Breakdown of academic impact, for papers by Saiju Jacob Breakdown of academic impact, for papers by Tena Rosser Breakdown of academic impact, for papers by Jean‐Philippe Camdessanché Breakdown of academic impact, for papers by Núria Solà‐Valls Breakdown of academic impact, for papers by Bianca Teegen Breakdown of academic impact, for papers by Sabrina Matà Breakdown of academic impact, for papers by Rinze F. Neuteboom Breakdown of academic impact, for papers by Jean‐Christophe Antoine Breakdown of academic impact, for papers by Salah Omer
Rankless by CCL
2026